Overview of GPR39: Structure, Function and Potential as A Drug Target

Target Name: GPR39

NCBI ID: G2863

GPR39

Other Name(s): G-protein coupled receptor 39 | G protein-coupled receptor 39 | GPR39_HUMAN

Overview of GPR39: Structure, Function and Potential as A Drug Target

G-protein coupled receptor 39 (GPR39) is a protein that plays an important role in cellular signaling. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling. GPR39 is expressed in many different tissues and cells in the body, including the brain, pancreas, and testes.

GPR39 is involved in a wide range of physiological processes in the body, including sensory perception, neurotransmitter signaling, and hormone regulation. It is also involved in diseases such as diabetes, hypertension, and obesity.

Despite its importance, GPR39 is not well understood. little is known about the structure and function of GPR39. The primary goal of this article is to provide an overview of GPR39, including its structure, function, and potential as a drug target.

Structure
GPR39 is a 19-kDa protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in cell adhesion and interaction with other proteins. The transmembrane domain is responsible for the transmembrane transportation of GPR39 and is involved in the signaling process. The intracellular domain is involved in the interaction with GPR signaling pathway.

Function
GPR39 is involved in a wide range of physiological processes in the body. It is involved in sensory perception, neurotransmitter signaling, and hormone regulation.

In sensory perception, GPR39 is involved in the sense of touch. It is thought to play a key role in the development of chronic pain.

In neurotransmitter signaling, GPR39 is involved in the signaling of neurotransmitters such as dopamine, serotonin, and GABA. It is also involved in the regulation of neurotransmitter release and uptake.

In hormone regulation, GPR39 is involved in the regulation of insulin sensitivity. It is also thought to play a key role in the development of obesity.

GPR39 is also involved in diseases such as diabetes, hypertension, and obesity. Studies have shown that GPR39 is highly expressed in tissues that are rich in glucose and fat, and that it is involved in the regulation of glucose and fat metabolism.

Potential as a drug target
GPR39 is a potential drug target due to its involvement in a wide range of physiological processes in the body.

One of the potential drug targets for GPR39 is the regulation of neurotransmitter signaling. GPR39 is involved in the signaling of neurotransmitters such as dopamine, serotonin, and GABA, and it is thought to play a key role in the regulation of neurotransmitter release and uptake. Therefore, drugs that can modulate neurotransmitter signaling by blocking GPR39 or its downstream targets may be useful in treating a wide range of neuropsychiatric and neurological disorders.

Another potential drug target for GPR39 is the regulation of insulin sensitivity. GPR39 is involved in the regulation of insulin sensitivity and is thought to play a key role in the development of obesity. Therefore, drugs that can modulate insulin sensitivity by blocking GPR39 or its downstream targets may be useful in treating obesity and type 2 diabetes.

Conclusion
GPR39 is a protein that plays an important role in cellular signaling. It is a member of the G protein-coupled receptor family and is involved in a wide range of physiological processes in the body. Despite its importance, GPR39 is not well understood. The potential of GPR39 as a drug target is vast, and further studies are needed to fully understand its role in

Protein Name: G Protein-coupled Receptor 39

Functions: Zn(2+) acts as an agonist. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated mainly through G(q)-alpha and G(12)/G(13) proteins. Involved in regulation of body weight, gastrointestinal mobility, hormone secretion and cell death (By similarity)

The "GPR39 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR39 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets